Overview
Elizabeth Fabre practices practicing medicine in Paris, France.
Ms. Fabre is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), and EGFR Positive Lung Cancer.
She is actively involved in clinical research, co-authoring 78 peer reviewed articles and participating in 1 clinical trial.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Frequently Asked Questions about Elizabeth Fabre
Is Elizabeth Fabre a top-rated expert for Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Elizabeth Fabre is classified as an Distinguished expert for Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Elizabeth Fabre participate in research or clinical trials?
Yes. Elizabeth Fabre has published 78 articles and abstracts on conditions like Lung Cancer. You can view a list of Elizabeth Fabre's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Lung CancerMs. Fabre isDistinguished. Learn about Lung Cancer.
- Non-Small Cell Lung Cancer (NSCLC)Ms. Fabre isDistinguished. Learn about Non-Small Cell Lung Cancer (NSCLC).
- Advanced
- Small Cell Lung Cancer (SCLC)Ms. Fabre isAdvanced. Learn about Small Cell Lung Cancer (SCLC).
- Experienced
- Breast CancerMs. Fabre isExperienced. Learn about Breast Cancer.
- EGFR Positive Lung CancerMs. Fabre isExperienced. Learn about EGFR Positive Lung Cancer.
- Interstitial NephritisMs. Fabre isExperienced. Learn about Interstitial Nephritis.
- Lung AdenocarcinomaMs. Fabre isExperienced. Learn about Lung Adenocarcinoma.
- Lung MetastasesMs. Fabre isExperienced. Learn about Lung Metastases.
- Metastatic Brain TumorMs. Fabre isExperienced. Learn about Metastatic Brain Tumor.
- PericarditisMs. Fabre isExperienced. Learn about Pericarditis.
- PIK3CA-Related Overgrowth SpectrumMs. Fabre isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Renal Cell Carcinoma (RCC)Ms. Fabre isExperienced. Learn about Renal Cell Carcinoma (RCC).